New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2013
08:34 EDTRTIXRTI Biologics' BioCleanse allografts show positive clinical results
RTI Biologics announced results of a recent randomized prospective clinical study of BioCleanse-processed bone-patellar tendon-bone allografts used in anterior cruciate ligament reconstruction surgery. The study compares the clinical outcomes of BTB allografts processed using RTIís patented BioCleanse Tissue Sterilization Process with a control group consisting of aseptically-processed allografts from the three U.S. tissue banks that provide this type of allograft. Results indicate that the sterilization process, BioCleanse, did not demonstrate a statistical difference in clinical outcomes for the BTB allograft at two years. The BioCleanse process may provide surgeons with allografts clinically similar to aseptically-processed allograft tissue with the benefit of addressing donor-to-recipient disease.
News For RTIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
08:03 EDTRTIXRTI Surgical sees Q4 revenue $68M-$69M, consensus $65.13M.
Subscribe for More Information
08:02 EDTRTIXRTI Surgical narrows FY14 adjusted EPS view to 11c from 9c-11c range
Fy14 EPS consensus 10c. Narrows FY14 revenue view to $260M-$261M from $258M-$261M, consensus $249.13M.
08:01 EDTRTIXRTI Surgical reports Q3 adjusted EPS 3c, consensus 2c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use